REMEDY.HEREMEDY.HEHEL
Loading
EBITDA Over TimeExpanding
Percentile Rank82
3Y CAGR+114.4%
5Y CAGR-0.1%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+114.4%/yr
vs +7.4%/yr prior
5Y CAGR
-0.1%/yr
Recent acceleration
Acceleration
+107.0pp
Accelerating
Percentile
P82
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$14.42M+413.8%
2024$2.81M+111.5%
2023$-24.48M-1771.9%
2022$1.46M-90.0%
2021$14.61M+1.0%
2020$14.47M+96.7%
2019$7.36M+567.6%
2018$1.10M-50.7%
2017$2.23M-47.7%
2016$4.27M-